DrugJan 18, 2023
Northern VA Compounders PLLC QuadMix Super 002 recall — FDA D-0108-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
Latest records
Latest recalls — page 296
The newest recall records with useful source details are listed here.
DrugJan 18, 2023
Northern VA Compounders PLLC Prostaglandin (E1) Injection Solution, 25mcg/ml, 2.5 mL recall — FDA D-0111-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Injection recall — FDA D-0121-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Injection recall — FDA D-0116-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC Mitomycin Injection Solution, 4mg/ml recall — FDA D-0102-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Nephron Sterile Compounding Center Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x recall — FDA D-0099-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNephron Sterile Compounding Center LLC
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Injection recall — FDA D-0126-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Original recall — FDA D-0106-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC Prostaglandin (E1) Injection Solution, 40mcg/ml, 2.5 mL recall — FDA D-0112-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC Prostaglandin (E1) Injection Solution, 20 mcg/ml, 2.5 mL recall — FDA D-0110-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC QuadMix Injectable recall — FDA D-0120-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC BiMix STD 001 recall — FDA D-0125-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC QuadMix Injectable recall — FDA D-0124-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC Methylcobalamin Injection Solution, 12.5mg/ml recall — FDA D-0119-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Injection recall — FDA D-0118-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC TriMix Injection recall — FDA D-0115-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 18, 2023
Northern VA Compounders PLLC QuadMix Plus recall — FDA D-0103-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedNorthern VA Compounders PLLC
DrugJan 11, 2023
Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL) recall — FDA D-0095-2023
Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
Class IIFDA: OngoingEugia US LLC
DrugJan 11, 2023
Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride recall — FDA D-0097-2023
Lack of assurance of sterility: Bags have the potential to leak.
Class IIFDA: CompletedPfizer Inc.
VehicleJan 5, 2023
Volvo Car USA steering recall — NHTSA campaign 23V001000
Volvo Car USA, LLC (Volvo Car) is recalling certain 2019-2022 V60CC, XC60, and XC90 vehicles. During steering gear assembly, double screws may have been assembled on top of each other,…
steeringVolvo Car USA, LLC
DrugJan 4, 2023
Apotex Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL recall — FDA D-0093-2023
Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.
Class IIIFDA: TerminatedApotex Corp.
DrugJan 4, 2023
Ganciclovir for Injection, USP, 500mg per vial recall — FDA D-0090-2023
Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.
Class IIFDA: TerminatedHikma Pharmaceuticals USA Inc.
DrugJan 4, 2023
NCH Life Sciences Alcohol Antiseptic 80% Topical Solution Hand Sanitizer, Non-Sterile recall — FDA D-0092-2023
CGMP Deviations: Impurities of acetal and acetaldehyde were discovered in the product in excess of allowed limits.
Class IIFDA: CompletedNCH Life Sciences LLC
DrugDec 28, 2022
Quinapril Tablets USP, 40 mg (90 pack) recall — FDA D-0088-2023
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories